These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 24500220

  • 1. Percutaneous renal denervation and the second generation EnligHTN System.
    Chokka RG, Delacroix S, Psaltis PJ, Anavekar NS, Worthley SG.
    Minerva Cardioangiol; 2014 Feb; 62(1):99-104. PubMed ID: 24500220
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial.
    Worthley SG, Tsioufis CP, Worthley MI, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Papademetriou V.
    Eur Heart J; 2013 Jul; 34(28):2132-40. PubMed ID: 23782649
    [Abstract] [Full Text] [Related]

  • 3. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
    Papademetriou V, Tsioufis CP, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Worthley MI, Worthley SG.
    Hypertension; 2014 Sep; 64(3):565-72. PubMed ID: 24935940
    [Abstract] [Full Text] [Related]

  • 4. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
    Worthley SG, Wilkins GT, Webster MW, Montarello JK, Delacroix S, Whitbourn RJ, Warren RJ.
    Atherosclerosis; 2017 Jul; 262():94-100. PubMed ID: 28531827
    [Abstract] [Full Text] [Related]

  • 5. Percutaneous renal sympathetic denervation: 2013 and beyond.
    Froeschl M, Hadziomerovic A, Ruzicka M.
    Can J Cardiol; 2014 Jan; 30(1):64-74. PubMed ID: 24365191
    [Abstract] [Full Text] [Related]

  • 6. Catheter-based renal sympathetic denervation: limitations to and gaps in the evidence.
    Hiremath S, Froeschl M, Ruzicka M.
    Curr Opin Cardiol; 2014 Jul; 29(4):336-43. PubMed ID: 24859619
    [Abstract] [Full Text] [Related]

  • 7. [Renal denervation a new treatment option in resistant arterial hypertension].
    Himmel F, Bode F, Schunkert H, Weil J.
    Praxis (Bern 1994); 2011 Nov 02; 100(22):1353-60. PubMed ID: 22048911
    [Abstract] [Full Text] [Related]

  • 8. Catheter-based renal denervation for resistant hypertension: Twenty-four month results of the EnligHTN I first-in-human study using a multi-electrode ablation system.
    Tsioufis CP, Papademetriou V, Dimitriadis KS, Kasiakogias A, Tsiachris D, Worthley MI, Sinhal AR, Chew DP, Meredith IT, Malaiapan Y, Thomopoulos C, Kallikazaros I, Tousoulis D, Worthley SG.
    Int J Cardiol; 2015 Dec 15; 201():345-50. PubMed ID: 26301677
    [Abstract] [Full Text] [Related]

  • 9. Number of ablated spots in the course of renal sympathetic denervation in CKD patients with uncontrolled hypertension: EnligHTN vs. Standard irrigated cardiac ablation catheter.
    Kiuchi MG, Chen S, Rodrigues Paz LM, Pürerfellner H.
    Hipertens Riesgo Vasc; 2018 Dec 15; 35(2):54-63. PubMed ID: 28784273
    [Abstract] [Full Text] [Related]

  • 10. Comparison of new-generation renal artery denervation systems: assessing lesion size and thermodynamics using a thermochromic liquid crystal phantom model.
    Al Raisi SI, Barry MT, Qian P, Bhaskaran A, Pouliopoulos J, Kovoor P.
    EuroIntervention; 2017 Nov 20; 13(10):1242-1247. PubMed ID: 28741577
    [Abstract] [Full Text] [Related]

  • 11. Renal denervation for hypertension.
    Eleid MF, Schwartz GL, Gulati R.
    Curr Probl Cardiol; 2014 Feb 20; 39(2):35-51. PubMed ID: 24412003
    [Abstract] [Full Text] [Related]

  • 12. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
    Khan NA, Herman RJ, Quinn RR, Rabkin SW, Ravani P, Tobe SW, Feldman RD, Wijeysundera HC, Padwal RS, Canadian Hypertension Education Program.
    Can J Cardiol; 2014 Jan 20; 30(1):16-21. PubMed ID: 24269056
    [Abstract] [Full Text] [Related]

  • 13. Effects of renal sympathetic denervation on cardiac sympathetic activity and function in patients with therapy resistant hypertension.
    van Brussel PM, Eeftinck Schattenkerk DW, Dobrowolski LC, de Winter RJ, Reekers JA, Verberne HJ, Vogt L, van den Born BJ.
    Int J Cardiol; 2016 Jan 01; 202():609-14. PubMed ID: 26447672
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of lesion and thermodynamic characteristics of Symplicity and EnligHTN renal denervation systems in a phantom renal artery model.
    Al Raisi SI, Pouliopoulos J, Barry MT, Swinnen J, Thiagalingam A, Thomas SP, Sivagangabalan G, Chow C, Chong J, Kizana E, Kovoor P.
    EuroIntervention; 2014 Jun 01; 10(2):277-84. PubMed ID: 24952062
    [Abstract] [Full Text] [Related]

  • 15. The future for renal denervation depends on embracing the lessons learned from our previous studies.
    Epstein M.
    J Am Soc Hypertens; 2016 May 01; 10(5):396-8. PubMed ID: 27079956
    [Abstract] [Full Text] [Related]

  • 16. [Renal artery denervation for treating refractory hypertension].
    Benamer H, Louvard Y, Garot P, Unterseeh T, Hovasse T, Lefèvre T, Chevalier B, Morice MC.
    Ann Cardiol Angeiol (Paris); 2011 Dec 01; 60(6):354-60. PubMed ID: 22040858
    [Abstract] [Full Text] [Related]

  • 17. 3D-sympathetic renal denervation increases procedural efficacy in non-responders after percutaneous renal denervation: dream or reality with second generation of devices.
    Versaci F, Nardi S, Trivisonno A, Olivieri C, Caranci F, Prati F.
    Int J Cardiol; 2014 Aug 01; 175(2):370-1. PubMed ID: 24820742
    [No Abstract] [Full Text] [Related]

  • 18. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D, Lucas N, Kuehnert H, Figulla HR, Surber R.
    EuroIntervention; 2012 Jan 01; 7(9):1077-80. PubMed ID: 21959556
    [Abstract] [Full Text] [Related]

  • 19. Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity system.
    Kaiser L, Beister T, Wiese A, von Wedel J, Meincke F, Kreidel F, Busjahn A, Kuck KH, Bergmann MW.
    EuroIntervention; 2014 May 01; 10(1):157-65. PubMed ID: 24472799
    [Abstract] [Full Text] [Related]

  • 20. Renal Denervation: Where to Now?
    Wimmer NJ, Mauri L.
    Curr Cardiol Rep; 2015 Dec 01; 17(12):116. PubMed ID: 26482759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.